학술논문

The positive influence the Onchocerciasis Elimination Program for the Americas has had on Africa programs
Document Type
article
Source
Infectious Diseases of Poverty, Vol 8, Iss 1, Pp 1-4 (2019)
Subject
Onchocerciasis
Elimination
Ivermectin mass drug administration
Onchocerciasis control Programme for West Africa
Test for antibody to Onchocerca volvulus 16 kDa antigen
Infectious and parasitic diseases
RC109-216
Public aspects of medicine
RA1-1270
Language
English
ISSN
2049-9957
Abstract
Abstract A recent article “Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes” in Infectious Diseases of Poverty claimed that undue influence on African programs by concepts developed by the Onchocerciasis Elimination Program of the Americas (OEPA) is detrimental to stopping mass drug administration (MDA) in Africa. This claim is made despite a record year for MDA stoppage in four African countries of > 3.5 million treatments in 2018, far exceeding any past OEPA or African Program for Onchocerciasis Control (APOC) stop MDA success.